LSD - COFEPRIS Registration 2195R2021 SSA
Access comprehensive regulatory information for LSD (LSD) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 2195R2021 SSA and manufactured by PRODUCTOS ROCHE,S.A. DE C.V.. The device was registered on December 17, 2021.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
ESTA PRUEBA DE DIAGNÓSTICO IN VITROLYSERGIC ACID DIETHYLAMIDE (LSD) ESTÁCONCEBIDA PARA LA DETECCIÓNCUALITATIVADELADIETILAMIDADELÁCIDOLISÉRGICO (LSD) Y SUS METABOLITOS ENORINAHUMANAENLOSSISTEMASROCHEAUNPUNTODECORTEDE0.5NG/ML. AGENTEDEDIAGNÓSTICOPARAUSOINVITRO. PARAUSOEXCLUSIVOENLABORATORIOSCLÍNICOSO DE GABINETES.
THIS IN VITROLYSERGIC ACID DIETHYLAMIDE (LSD) DIAGNOSTIC TEST IS DESIGNED FOR THE QUALITATIVE DETECTION OF LYSERGIC ACID (LSD) ADIETHYLAMIDE AND ITS METABOLITES IN HUMAN URINE IN THE SYSTEMS AT A CUT-OFF POINT OF 0.5NG/ML. DIAGNOSTIC AGENT FOR INVITRO USE. FOR EXCLUSIVE USE IN CLINICAL LABORATORIES OR CABINETS.